NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
Australia · Delayed Price · Currency is AUD 0.1400
+0.0050 (3.70%)
Jan 30, 2026, 4:10 PM AEST
ASX:NSB Market Cap
ASX:NSB has a market cap or net worth of 44.9 million as of January 29, 2026. Its market cap has increased by 762.46% in one year.
Market Cap
44.90M
Enterprise Value
37.63M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.14
Market Cap Chart
Since July 27, 2018, ASX:NSB's market cap has increased from 16.56M to 44.90M, an increase of 171.19%. That is a compound annual growth rate of 14.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 44.90M | 22.73% |
| Dec 31, 2025 | 36.58M | 666.63% |
| Dec 30, 2024 | 4.77M | -25.00% |
| Dec 29, 2023 | 6.36M | -64.52% |
| Dec 29, 2022 | 17.93M | -62.69% |
| Dec 31, 2021 | 48.06M | 116.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alterity Therapeutics | 87.00M |
| EZZ Life Science Holdings | 86.32M |
| Radiopharm Theranostics | 81.52M |
| Prescient Therapeutics | 79.92M |
| Cynata Therapeutics | 77.36M |
| Amplia Therapeutics | 71.83M |
| Neurizon Therapeutics | 51.67M |
| Entropy Neurodynamics | 49.95M |